Biotech funding on track to bounce back

Biotech funding on track to bounce back
It’s not over yet, but 2003 already looks like a banner year for biotechnology funding in the United States, according to a survey released yesterday by the accounting firm Ernst & Young.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!